What are the recent trends in market size and growth for the medical isotopes market?
The medical isotopes market size has grown strongly in recent years. It will grow from $6.8 billion in 2024 to $7.35 billion in 2025 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to the rising incidence of chronic diseases, expansion of the pharmaceutical industry, advancements in cancer treatment, demand for diagnostic imaging, and advancements in nuclear medicine.
The medical isotopes market size is expected to see strong growth in the next few years. It will grow to $9.92 billion in 2029 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to public health initiatives, partnerships and collaborations, investment in infrastructure, a shift towards personalized medicine, a growing geriatric population, regulatory changes, and standards. Major trends in the forecast period include growth in radiopharmaceuticals, adoption of cyclotron and generator technologies, focus on supply chain resilience, integration of artificial intelligence (AI), and advancements in positron emission tomography (PET) imaging.
Get Your Free Sample of The Global Medical Isotopes Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15853&type=smp
What have been the primary factors driving the medical isotopes market’s growth?
The rising cancer and heart disease rates are expected to propel the growth of the medical isotope market going forward. Cancer and heart disease rates refer to the frequency of new cases and prevalence of these diseases within a population over a specified period, providing insights into public health trends and the effectiveness of preventive measures. The increasing prevalence of cancer and heart disease correlates with the widespread sedentary lifestyle encouraged by modern technology and desk-bound occupations, resulting in reduced levels of physical activity. Medical isotopes are used to diagnose and treat cancer and heart disease through imaging techniques such as positron emission tomography (PET) and single photon emission computed tomography (SPECT) scans and therapies such as radiation therapy and radioactive stents. For instance, in February 2024, according to the World Health Organization, a Switzerland-based intergovernmental organization, by 2050, over 35 million new cancer cases were projected, representing a 77% increase compared to the estimated 20 million cases in 2022. Additionally, in September 2024, according to the data published by the British Heart Foundation, a UK-based cardiovascular research charity, in the UK, approximately 7.6 million people are affected by heart and circulatory diseases, with around 4 million males and 3.6 million females living with these conditions. These diseases are responsible for about 27% of all deaths in the UK, translating to over 170,000 deaths annually, or roughly 480 deaths each day, equating to one death every three minutes. Therefore, the rising cancer and heart disease rates are driving the growth of the medical isotope market.
What are the key segments within the medical isotopes market?
The medical isotopes market covered in this report is segmented –
1) By Product Type: Stable Isotopes, Radio Isotopes
2) By Production Method: Neutron Activation, Cyclotron, Nuclear Reactor, Other Production Method
3) By Application: Nuclear Therapy, Equipment Radioactive Source, Diagnosis
4) By End Use: Hospitals, Diagnostic Centers, Research Institutes
Subsegments:
1) By Stable Isotopes: Carbon-13, Nitrogen-15, Oxygen-18, Other Stable Isotopes
2) By Radio Isotopes: Technetium-99m, Iodine-131, Cobalt-60, Strontium-89, Other Radio Isotopes
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/medical-isotopes-global-market-report
Which key players are shaping the medical isotopes market?
Major companies operating in the medical isotopes market are Rosatom State Atomic Energy Corporation, Bayer AG, Siemens Healthineers AG, GE HealthCare, Urenco Ltd., Lantheus Holdings Inc., Curium Pharma, Canadian Nuclear Laboratories, Eckert & Ziegler Strahlen- und Medizintechnik AG., Advanced Accelerator Applications a Novartis company, Nordion Inc., NTP Radioisotopes SOC Ltd., The Institute for Radioelements (IRE), NorthStar Medical Radioisotopes LLC, Isotopen Technologien München AG (ITM), Eczacıbaşı-Monrol Nuclear Products Co., SHINE Medical Technologies LLC, Blue Earth Diagnostics Limited, Isologic Innovative Radiopharmaceuticals, IBA Radiopharma Solutions, Izotóp, Coquí RadioPharmaceuticals Corp., Jubilant DraxImage Inc., Positron Corporation
How will emerging trends drive the medical isotopes market throughout the forecast period?
Major companies operating in the medical isotope market are focusing on strategic collaborations to gain a competitive edge in the market. Strategic collaboration is a formal agreement between two or more parties to work together toward achieving specific, predetermined goals that are mutually beneficial. For instance, in September 2023, International Isotopes Inc., a US-based medical technology company partnered with Phantech Medical, a US-based biomedical hardware company to integrate the solutions for customers. With this partnership, they aim to revolutionize the calibration and reference sources market for pre-clinical imaging by designing, manufacturing, and distributing innovative sealed sources for the medical imaging and theranostics communities.
How do regional factors impact the medical isotopes market, and which region is the largest contributor?
North America was the largest region in the medical isotopes market in 2024. The regions covered in the medical isotopes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Medical Isotopes Market Report 2025 Offer?
The medical isotopes market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Medical isotopes are radioactive isotopes used in medical imaging, diagnosis, and therapy. They emit radiation that can be detected by imaging devices, providing vital information about biological processes in the body. Common examples include Technetium-99m for imaging and Iodine-131 for treating thyroid conditions.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15853
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
